CN104784482A - Traditional Chinese medicine for treating chronic pyogenic osteomyelitis - Google Patents
Traditional Chinese medicine for treating chronic pyogenic osteomyelitis Download PDFInfo
- Publication number
- CN104784482A CN104784482A CN201510167437.9A CN201510167437A CN104784482A CN 104784482 A CN104784482 A CN 104784482A CN 201510167437 A CN201510167437 A CN 201510167437A CN 104784482 A CN104784482 A CN 104784482A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- radix
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of traditional Chinese medicine preparations, and particularly relates to a traditional Chinese medicine for treating chronic pyogenic osteomyelitis. The traditional Chinese medicine is prepared from the following raw materials: 10-15 parts of radix sanguisorbae, 10-15 parts of flos carthami, 10-15 parts of Chinese maple roots, 15-20 parts of euphorbia helioscopia, 5-10 parts of pholidota chinensis, 15-20 parts of guling berchemia roots, 10-15 parts of achyranthes bidentata and 5-10 parts of centipedes. The traditional Chinese medicine is prepared from traditional Chinese medicine materials after repeated verification of clinical tests; components are scientific, reasonable and uniquely compatible; the traditional Chinese medicine has the efficacy of blood activation, promotion of qi circulation, inflammation elimination, carbuncle elimination and the like, accords with traditional Chinese medicine theories, has a remarkable curative effect on chronic pyogenic osteomyelitis, is convenient to take, takes effect quickly, is free of toxic and side effects and has good economic and social benefits; a preparation method is simple and easy to operate; the course of treatment is short; medicine dependence cannot be caused.
Description
Technical field
The invention belongs to technical field of traditional Chinese medicine preparation, be specifically related to a kind of Chinese medicine for the treatment of chronic suppurative osteomyelisis.
Background technology
Chronic suppurative osteomyelisis refers to that suppurative bacterium infects bone marrow, cortical bone and periosteum and the diseases associated with inflammation caused, majority is caused by haematogenous, also how to be caused by wound or postoperative infection, how enter blood by the suppuration bacterium of furuncle carbuncle or other focuses and reach osseous tissue, bones of limbs two ends are subject to invade most, especially be the most common with hip joint, common clinically have recurrent exerbation, the case do not healed for many years, have a strong impact on physical and mental health and work capacity, high heat during acute chronic suppurative osteomyelisis onset, local pain, if diagnosis has diabrosis when transferring chronic chronic suppurative osteomyelisis not in time to, flow dense, sequestrum or cavity is had to be formed, the normal threat to life of patient with severe symptoms, sometimes to have to the emergency approach taking amputation to save one's life, patient is made to fall lifelong disability.
At present, the treatment of chronic suppurative osteomyelisis generally adopts comprehensive therapy, comprise Western medicine colligation treatment, traditional medicine synthetic therapy and Integrative medicine therapy, wherein better with Integrative medicine therapy effect in disability rate, but still lack effective medicine.The compound medicines function singleness of current treatment chronic suppurative osteomyelisis, drug matching is mixed and disorderly, take effect slowly, and doctor trained in Western medicine can only take the way of blood vessel dilating, can only temporary relieve, cure the symptoms, not the disease, and the recovery process of chronic suppurative osteomyelisis is very long, need patient treatment, if control by Chinese medicine early stage, post-operative treatment is just very smooth.
Summary of the invention
The present invention is directed to chronic suppurative osteomyelisis Treatment defect to study, disclose a kind of Chinese medicine for the treatment of chronic suppurative osteomyelisis.
The present invention is by following technology implementation: Radix Sanguisorbae 10-15 part, Flos Carthami 10-15 part, Cortex Aceris Sinensis 10-15 part, Herba Euphorbiae Helioscopiae 15-20 part, Pseudobulbus Pholidotae Chinensis 5-10 part, Radix berchemiae kulingensis 15-20 part, Radix Achyranthis Bidentatae 10-15 part, Scolopendra 5-10 part; Its preparation flow is: dried by above-mentioned each component, sterilize; Then abundant mix homogeneously; Add the water of 3-4 times of said medicine weight, intense fire steaming and decocting, to boiling, keeps boiling steaming and decocting 10-20 minute; Change slow fire and boil 30-40 minute; Cold filtration, gets filtrate; Got filtrate is concentrated into paste further, adopts common process to make close ball.
Preferably, it is made up of following composition of raw materials: Radix Sanguisorbae 15 parts, 15 parts, Flos Carthami, Cortex Aceris Sinensis 15 parts, Herba Euphorbiae Helioscopiae 20 parts, Pseudobulbus Pholidotae Chinensis 10 parts, Radix berchemiae kulingensis 20 parts, Radix Achyranthis Bidentatae 15 parts, Scolopendra 10 parts.
In the present invention, the drug effect of all kinds of Chinese medicine is:
Flos Carthami, Radix Achyranthis Bidentatae, Lignum Dalbergiae Odoriferae lead to the principal agent of carbuncle for logical blood of invigorating blood circulation, blood stasis dispelling, and Herba Euphorbiae Helioscopiae can play Accessory Effect as ministerial drug, increase the effect of relaxing muscles and tendons to promote blood circulation; Radix berchemiae kulingensis, Cortex Aceris Sinensis are a class medicine, mainly play the effect of regulate the flow of vital energy analgesia, expelling wind and removing dampness; Pseudobulbus Pholidotae Chinensis can pulverize external, also oral administration, plays mutual reinforcement between effect as tonic in mixing prescription.
Beneficial effect of the present invention: scientific formula of the present invention is reasonable, compatibility is original, there is the effect such as blood circulation promoting and blood stasis dispelling, sensible QI and blood, expansible blood vessel, the dredging of increase joint, meet the theory of Chinese medicine, evident in efficacy to chronic suppurative osteomyelisis, and manufacture method is simple and easy to do, taking convenience, short treating period, instant effect, have no side effect, there is good economy profit social benefit.
Detailed description of the invention
Embodiment 1
It is made up of following composition of raw materials: Radix Sanguisorbae 15 parts, 15 parts, Flos Carthami, Cortex Aceris Sinensis 15 parts, Herba Euphorbiae Helioscopiae 20 parts, Pseudobulbus Pholidotae Chinensis 10 parts, Radix berchemiae kulingensis 20 parts, Radix Achyranthis Bidentatae 15 parts, Scolopendra 10 parts.
Above-mentioned preparation method: first above-mentioned each component dried, sterilize; Then abundant mix homogeneously; Add the water of 3-4 times of said medicine weight, intense fire steaming and decocting, to boiling, keeps boiling steaming and decocting 10-20 minute; Change slow fire and boil 30-40 minute; Cold filtration, gets filtrate.Got filtrate is concentrated into paste further, adopts common process to make close ball.
Poplar, female, 53 years old.Time medical, clinical symptoms is: arthralgia, and backfin bores bone pain.After taking 2 courses for the treatment of of medicine pill of the present invention by above-mentioned administrated method, clinical symptoms is clearly better, after continuing to take 2 courses for the treatment of of described Chinese medicine, various clinical symptoms all disappears, when following up a case by regular visits to medication half a year after drug withdrawal, have no recurrence, chronic suppurative osteomyelisis is fully recovered.
Embodiment 2
It is made up of following composition of raw materials: Radix Sanguisorbae 10 parts, 10 parts, Flos Carthami, Cortex Aceris Sinensis 10 parts, Herba Euphorbiae Helioscopiae 15 parts, Pseudobulbus Pholidotae Chinensis 5 parts, Radix berchemiae kulingensis 15 parts, Radix Achyranthis Bidentatae 10 parts, Scolopendra 5 parts.
Above-mentioned preparation method: first above-mentioned each component dried, sterilize; Then abundant mix homogeneously; Add the water of 3-4 times of said medicine weight, intense fire steaming and decocting, to boiling, keeps boiling steaming and decocting 10-20 minute; Change slow fire and boil 30-40 minute; Cold filtration, gets filtrate.Got filtrate is concentrated into paste further, adopts common process to make close ball.
Embodiment 3
It is made up of following composition of raw materials: Radix Sanguisorbae 13 parts, 13 parts, Flos Carthami, Cortex Aceris Sinensis 13 parts, Herba Euphorbiae Helioscopiae 17 parts, Pseudobulbus Pholidotae Chinensis 7 parts, Radix berchemiae kulingensis 17 parts, Radix Achyranthis Bidentatae 13 parts, Scolopendra 7 parts.
Above-mentioned preparation method: first above-mentioned each component dried, sterilize; Then abundant mix homogeneously; Add the water of 3-4 times of said medicine weight, intense fire steaming and decocting, to boiling, keeps boiling steaming and decocting 10-20 minute; Change slow fire and boil 30-40 minute; Cold filtration, gets filtrate.Got filtrate is concentrated into paste further, adopts common process to make close ball.
Comparative example:
Outpatient service be diagnosed as chronic suppurative osteomyelisis patient 186 example, male 77 example, women 109 example, age characteristics 17-65 year.Random point two groups, wherein treatment group 102 example, matched group 84 example.
Treatment group uses the medicament obtained by the present invention, each 10g, every day 3 times; Matched group buccal levofloxacin hydrochloride dispersible tablet, a 0.2g, 2 times on the one, often organizing equal seven days is a course for the treatment of.
Contrast standard: diagnose weekly once, treatment conditioning one month, various transference cure is bitter without institute, follows up a case by regular visits to so far, has no repeatedly.
Comparative test result sees the following form:
Clinical observation on the therapeutic effect table
| Effectively | Invalid | Cure rate | |
| Treatment group 1 | 99 examples | 3 examples | 97％ |
| Treatment group 2 | 90 examples | 12 examples | 88％ |
| Treatment group 3 | 94 examples | 8 examples | 92％ |
| Matched group | 72 examples | 12 examples | 86％ |
From upper result, the levofloxacin hydrochloride dispersible tablet that the medicament that the present invention treating three groups of uses obtain is taken than matched group can cure chronic suppurative osteomyelisis more effectively, and wherein the effect for the treatment of group 1 is best.
Claims (4)
1. treat a Chinese medicine for chronic suppurative osteomyelisis, it is characterized in that: it is made up of following composition of raw materials: Radix Sanguisorbae 10-15 part, Flos Carthami 10-15 part, Cortex Aceris Sinensis 10-15 part, Herba Euphorbiae Helioscopiae 15-20 part, Pseudobulbus Pholidotae Chinensis 5-10 part, Radix berchemiae kulingensis 15-20 part, Radix Achyranthis Bidentatae 10-15 part, Scolopendra 5-10 part; Its preparation flow is: dried by above-mentioned each component, sterilize; Then abundant mix homogeneously; Add the water of 3-4 times of said medicine weight, intense fire steaming and decocting, to boiling, keeps boiling steaming and decocting 10-20 minute; Change slow fire and boil 30-40 minute; Cold filtration, gets filtrate; Got filtrate is concentrated into paste further, adopts common process to make close ball.
2. a kind of Chinese medicine for the treatment of chronic suppurative osteomyelisis according to claim 1, is characterized in that: it is made up of following composition of raw materials: Radix Sanguisorbae 13 parts, 13 parts, Flos Carthami, Cortex Aceris Sinensis 13 parts, Herba Euphorbiae Helioscopiae 17 parts, Pseudobulbus Pholidotae Chinensis 7 parts, Radix berchemiae kulingensis 17 parts, Radix Achyranthis Bidentatae 13 parts, Scolopendra 7 parts.
3. a kind of Chinese medicine for the treatment of chronic suppurative osteomyelisis according to claim 1, is characterized in that: it is made up of following composition of raw materials: Radix Sanguisorbae 10 parts, 10 parts, Flos Carthami, Cortex Aceris Sinensis 10 parts, Herba Euphorbiae Helioscopiae 15 parts, Pseudobulbus Pholidotae Chinensis 5 parts, Radix berchemiae kulingensis 15 parts, Radix Achyranthis Bidentatae 10 parts, Scolopendra 5 parts.
4. a kind of Chinese medicine for the treatment of chronic suppurative osteomyelisis according to claim 1, is characterized in that: it is made up of following composition of raw materials: Radix Sanguisorbae 15 parts, 15 parts, Flos Carthami, Cortex Aceris Sinensis 15 parts, Herba Euphorbiae Helioscopiae 20 parts, Pseudobulbus Pholidotae Chinensis 10 parts, Radix berchemiae kulingensis 20 parts, Radix Achyranthis Bidentatae 15 parts, Scolopendra 10 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510167437.9A CN104784482A (en) | 2015-04-10 | 2015-04-10 | Traditional Chinese medicine for treating chronic pyogenic osteomyelitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510167437.9A CN104784482A (en) | 2015-04-10 | 2015-04-10 | Traditional Chinese medicine for treating chronic pyogenic osteomyelitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104784482A true CN104784482A (en) | 2015-07-22 |
Family
ID=53549973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510167437.9A Pending CN104784482A (en) | 2015-04-10 | 2015-04-10 | Traditional Chinese medicine for treating chronic pyogenic osteomyelitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104784482A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106581378A (en) * | 2016-12-31 | 2017-04-26 | 胡鲲 | Traditional Chinese medicine paste for treating chronic pyogenic osteomyelitis and preparation method thereof |
| CN113425746A (en) * | 2021-06-25 | 2021-09-24 | 楚东开 | Composition for treating pyogenic osteomyelitis and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520513A (en) * | 2013-08-08 | 2014-01-22 | 卢金贵仙 | Traditional Chinese medicine pill for treating ronic pyogenic osteomyelitis |
| CN104800385A (en) * | 2015-03-27 | 2015-07-29 | 济南正骐生物科技有限公司 | Traditional Chinese medicine for treating recurrent erysipelas |
| CN104888069A (en) * | 2015-05-29 | 2015-09-09 | 济南正骐生物科技有限公司 | Chinese medicinal spray for treating newborn eczema |
-
2015
- 2015-04-10 CN CN201510167437.9A patent/CN104784482A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520513A (en) * | 2013-08-08 | 2014-01-22 | 卢金贵仙 | Traditional Chinese medicine pill for treating ronic pyogenic osteomyelitis |
| CN104800385A (en) * | 2015-03-27 | 2015-07-29 | 济南正骐生物科技有限公司 | Traditional Chinese medicine for treating recurrent erysipelas |
| CN104888069A (en) * | 2015-05-29 | 2015-09-09 | 济南正骐生物科技有限公司 | Chinese medicinal spray for treating newborn eczema |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106581378A (en) * | 2016-12-31 | 2017-04-26 | 胡鲲 | Traditional Chinese medicine paste for treating chronic pyogenic osteomyelitis and preparation method thereof |
| CN106581378B (en) * | 2016-12-31 | 2020-04-07 | 胡鲲 | Traditional Chinese medicine ointment for treating chronic pyogenic osteomyelitis and preparation method thereof |
| CN113425746A (en) * | 2021-06-25 | 2021-09-24 | 楚东开 | Composition for treating pyogenic osteomyelitis and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102327478B (en) | Pharmaceutical composition for treating burns and scalds and preparation method thereof | |
| CN102188685B (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
| CN103191291A (en) | Traditional Chinese medicine composition for treating viral myocarditis | |
| CN103055260A (en) | Traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof | |
| CN102423444B (en) | Traditional Chinese medicine preparation for treating rheumatism and internal lesion caused by overexertion and preparation method thereof | |
| CN104784482A (en) | Traditional Chinese medicine for treating chronic pyogenic osteomyelitis | |
| CN103610841B (en) | A kind of method for the treatment of bamboo rat stomatitis | |
| CN105412426A (en) | Traditional Chinese medicine for lowering blood pressure | |
| CN104547936A (en) | Traditional Chinese medicine for treating local induration of vascular access of hemodialysis patient | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN101554438B (en) | Traditional Chinese medicine for curing hemorrhoids | |
| CN104800427A (en) | Burn and scald recovery application and preparation method thereof | |
| CN103690855A (en) | Traditional Chinese medicine composition for treating motility dysfunction-type dyspepsia | |
| CN104800385A (en) | Traditional Chinese medicine for treating recurrent erysipelas | |
| CN103550705B (en) | The composition and method of making the same for the treatment of Infectious Tracheobroncheitis | |
| CN116474058B (en) | Traditional Chinese medicine ointment for treating spleen enlargement | |
| CN106539910B (en) | Traditional Chinese medicine composition containing radix aconiti and application thereof | |
| CN104547718B (en) | A kind of pharmaceutical composition preventing and treating fracture of children internal fixation postoperative infection | |
| CN104758346A (en) | Medicine for treating migraine, as well as preparation method and preparation of medicine | |
| CN105213718A (en) | For the Chinese medicine composition of malignant arrhythmia | |
| CN105288436A (en) | Medicament for treatment of chronic eczema | |
| CN104888069A (en) | Chinese medicinal spray for treating newborn eczema | |
| CN105326972A (en) | External medicine composition for treating traumata and skin and external diseases | |
| CN101293004B (en) | Medicament for treating chyluria | |
| CN104666911A (en) | Medicine for treating urticaria and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150722 |